Rheumocam 15mg/ml Oral Suspension for Horses 250ml

Rheumocam meloxicam oral suspension for horses with musculo-skeletal pain

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. It acts by inhibiting prostaglandin synthesis, giving anti-inflammatory, analgesic, anti-exudative and antipyretic effects.

Rheumocam for horses is used for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. It is dosed by bodyweight at 0.6 mg/kg once daily, for up to 14 days, so body weight should be determined as accurately as possible.

Key features of Rheumocam 15mg/ml Oral Suspension for Horses 250ml:

• Active ingredient: meloxicam 15mg per ml.
• Honey-flavoured oral suspension: mixed with a small quantity of food before feeding, or given directly into the mouth.
• Measuring syringe included: fits onto the bottle and has a 2ml scale.
• 250ml bottle: the larger of the two Rheumocam horse pack sizes; use within 3 months of first opening.
• Not for horses less than 6 weeks of age, or pregnant or lactating mares.

For use under veterinary direction

Rheumocam is a prescription-only veterinary medicine. Your vet will set the dose for your horse's bodyweight and how long to give it. See our equine care range, the Rheumocam range and our guide to pet prescriptions.

Always follow the directions and dosage given to you by your prescriber.

Dosage

To be administered either mixed with food or directly into the mouth at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days.

Do not use in horses less than 6 weeks of age.

How to give it

• Shake well before use.
• In case the product is mixed with food, it should be added to a small quantity of food, prior to feeding.
• The suspension should be given using the Rheumocam measuring syringe provided in the package. The syringe fits onto the bottle and has a 2 ml scale.
• To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommended.
• Avoid introduction of contamination during use.
• After administration, close the bottle by replacing the cap, wash the measuring syringe with warm water and let it dry.

Before use

Do not use:

• in pregnant or lactating mares.
• in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
• in case of hypersensitivity to the active substance or to any of the excipients.
• in horses less than 6 weeks of age.

Special precautions for use in animals: Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.

Precautions for the person giving the product: People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Pregnancy and lactation: Laboratory studies in cattle have not provided any evidence for teratogenic, foetotoxic, or maternotoxic effects. However, no data have been generated in horses. Therefore the use in this species is not recommended during pregnancy and lactation.

Interactions: Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.

Withdrawal periods: Meat and offal: 3 days. Not authorised for use in animals producing milk for human consumption.

Adverse events and overdose

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Very rare (less than 1 animal in 10,000 treated, including isolated reports): appetite loss, lethargy, diarrhoea (reversible), abdominal pain, colitis, urticaria (reversible, slight), anaphylactoid reaction. Anaphylactoid reactions may be serious (including fatal); if such a reaction occurs, it should be treated symptomatically.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system.

Overdose: In the case of overdose, symptomatic treatment should be initiated.

Storage and disposal

• This product does not require any special storage conditions.
• Shelf life after first opening of the bottle: 3 months.
• Medicines should not be disposed of via wastewater. Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable.

Active ingredient: Meloxicam 15 mg per ml.

Other ingredients: Sodium benzoate 5 mg per ml, Saccharin sodium, Carmellose sodium, Silica colloidal anhydrous, Citric acid monohydrate, Sorbitol liquid (non-crystallising), Disodium phosphate dodecahydrate, Honey aroma, Purified water.

External content warning: this link will take you to a third party website.
We cannot guarantee the Patient Information Leaflet is accurate and is for reference only.